` BONS (Bonus Biogroup Ltd) vs Tel Aviv 355 Comparison - Alpha Spread

B
BONS
vs
T
Tel Aviv 355

Over the past 12 months, BONS has significantly outperformed Tel Aviv 355, delivering a return of +158% compared to the Tel Aviv 355's +53% growth.

Stocks Performance
BONS vs Tel Aviv 355

Loading
BONS
Tel Aviv 355
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BONS vs Tel Aviv 355

Loading
BONS
Tel Aviv 355
Difference
www.alphaspread.com

Performance By Year
BONS vs Tel Aviv 355

Loading
BONS
Tel Aviv 355
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Bonus Biogroup Ltd vs Peers

Tel Aviv 355
BONS
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Bonus Biogroup Ltd
Glance View

Market Cap
309.5m ILS
Industry
Biotechnology

Bonus Biogroup Ltd. is a biotechnology company engaging in the field of stem cells and tissue engineering. The firm is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. The company is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.

BONS Intrinsic Value
Not Available
B
Back to Top